Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novo Nordisk A/S ADR (NY: NVO ) 125.79 -0.37 (-0.29%) Official Closing Price Updated: 7:00 PM EDT, Apr 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,434,361 Open 123.69 Bid (Size) 125.51 (5) Ask (Size) 127.50 (1) Prev. Close 126.16 Today's Range 123.21 - 125.85 52wk Range 75.56 - 138.28 Shares Outstanding N/A Dividend Yield 1.41% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) a Strong Candidate for Quality Investing? April 25, 2024 Why NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) qualifies as a quality stock. Via Chartmill What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk April 24, 2024 Senate Committee probes Novo Nordisk's pricing tactics for diabetes and obesity meds. Sanders demands transparency on pricing, signaling broader industry scrutiny. Medicare coverage expansion could... Via Benzinga Performance YTD +23.19% +23.19% 1 Month -2.80% -2.80% 3 Month +19.03% +19.03% 6 Month +32.13% +32.13% 1 Year +52.48% +52.48% More News Read More 3 Biotech Stocks With Skyrocketing Potential: April 2024 April 24, 2024 Via InvestorPlace Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market April 24, 2024 Via The Motley Fool 3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains April 24, 2024 Via InvestorPlace Why Novo Nordisk Topped the Market Today April 22, 2024 Via The Motley Fool Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. April 24, 2024 Via The Motley Fool Better Buy: Pfizer vs. Viking Therapeutics April 23, 2024 Via The Motley Fool 3 Stocks With the Potential to Surpass Analyst Expectations for 2024 April 23, 2024 Via InvestorPlace Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending April 22, 2024 Via Benzinga Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs? April 22, 2024 Via MarketBeat 2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever April 20, 2024 Via The Motley Fool MarketBeat Week in Review – 4/15 - 4/19 April 20, 2024 Via MarketBeat Topics Economy Exposures Interest Rates 3 Relatively Safe Growth Stocks You Can Buy and Hold April 20, 2024 Via The Motley Fool 3 Biotech Stocks Set to Double by 2028 April 20, 2024 Via InvestorPlace Got $500? 3 Healthcare Stocks to Buy and Hold Forever April 19, 2024 Via The Motley Fool German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline April 18, 2024 Via Benzinga Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025 April 18, 2024 Via Benzinga How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher April 18, 2024 Via Investor's Business Daily Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank April 17, 2024 Via The Motley Fool Powell And The Great Indecision April 16, 2024 Via Talk Markets Topics Economy Exposures Economy Interest Rates These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come? April 16, 2024 Via InvestorPlace Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges April 16, 2024 Via InvestorPlace Topics ETFs Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead April 16, 2024 Via Talk Markets 3 Pharma Stocks That Are Money-Printing Machines in 2024 April 15, 2024 Via InvestorPlace Topics Economy Exposures Economy Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
